Patent · US Active

Therapy-enhancing glucan

US8323644B2 · kind B2 · utility

3Cited by

53References

14Claims

0Family size

Assignees

Sloan Kettering Institute for Cancer Research · US
Biotec Pharmacon Asa · NO

Inventors

Nai-Kong V. Cheung · New York, US
Rolf Engstad · Tromsø, NO

Key dates

Filing date	Jan 17, 2007
Grant date	Dec 4, 2012
Priority date	—
Expiry date	Jan 17, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55511
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a yeast beta-glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal. The above therapeutic composition may further comprise antitumor antibodies or cancer vaccine composition, wherein the antitumor activities of the antitumor antibodies or the cancer vaccine composition are enhanced by the yeast glucan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.